Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged Inhaled Nitric Oxide for NTM
NCT03473314Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2018
- Primary completion
- Jul 2020
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in Nontuberculous Mycobacterial Lung Disease (NTM-LD), sponsored by University of British Columbia. Started Mar 2018; status: completed.
02
Drugs
nitric oxide
03
Conditions
Nontuberculous Mycobacterial Lung Disease (NTM-LD)
Beyond the preview
Go deeper on NCT03473314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03473314.